---
cssClass:
- wide
tags:
  - ðŸ§ª
---

# `Title:` [[Hit-to-Lead]]
--- 

- What led me here: [[Drug Discovery]]

Inlinks
```dataview 
list from [[#this.file.name]] and !outgoing([[# this.file.name]]) 
```

The Hit-to-Lead (H2L) process is a critical phase in early drug discovery where initial 'hits'-
compounds that show potential biological activity against a target - are optimized into 'lead'
compounds. These leads are then further refined in the Lead Optimization (LO) stage.
## Overview
The H2L process involves the transformation of biologically active compounds into potential drug
candidates. This is achieved through a series of chemical modifications to improve the properties
of the compound, such as potency, selectivity, and pharmacokinetic profile.
## Technique
The H2L process typically involves the following steps:
1. **Hit Confirmation**: The initial hits are retested to confirm their activity. This often
involves testing the compounds in different concentrations and verifying the results.
2. **Hit Expansion**: Additional similar compounds are tested to explore the structure-activity
relationship (SAR). This helps to identify the chemical groups in the compound that are important
for its activity.
3. **Lead Generation**: The hits are optimized through chemical modifications to improve their
properties. This involves a balance between potency, selectivity, and drug-like properties.
4. **Lead Validation**: The lead compounds are tested in different assays to confirm their
activity and selectivity. They are also tested in preliminary ADME (Absorption, Distribution,
Metabolism, and Excretion) studies to evaluate their pharmacokinetic properties.
## Applications
The H2L process is a crucial step in drug discovery and development. It helps to identify
promising drug candidates that can be further optimized and tested in preclinical and clinical
studies
## Advantages and Limitations
The H2L process allows for the systematic optimization of compounds, increasing the chances of
identifying a successful drug candidate. However, it can be a time-consuming and costly process.
The success of the H2L process also heavily depends on the quality of the initial hits and the
availability of resources for testing and optimization.
## See Also
- [Drug Discovery] (https://en.wikipedia.org/wiki/Drug_discovery)
- [Pharmacokinetics](https://en.wikipedia.org/wiki/Pharmacokinetics)
## References
- Hughes, J. P., Rees, S., Kalindjian, S. B., & Philpott, K. L. (2011). Principles of early drug
discovery. British Journal of Pharmacology, 162(6), 1239-1249.
- KeserÃ¼, G. M., & Makara, G. M. (2009). Hit discovery and hit-to-lead approaches. Drug Discovery
Today, 14 (15-16), 741-747.